| scholarly article | Q13442814 |
| P50 | author | Steven Libutti | Q7614982 |
| Stephen M. Hewitt | Q30361876 | ||
| Joon-Yong Chung | Q39767989 | ||
| P2093 | author name string | Chel Hun Choi | |
| Jae-Hoon Kim | |||
| Juan Lin | |||
| Mijung Kwon | |||
| Alex Luna | |||
| Asha Adem | |||
| Elizabeth Tubridy | |||
| Yevangelina Rybak | |||
| P2860 | cites work | beta-Catenin is a Nek2 substrate involved in centrosome separation | Q24303972 |
| Conductin/axin2 and Wnt signalling regulates centrosome cohesion | Q24304045 | ||
| Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway | Q24324821 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| CellProfiler: image analysis software for identifying and quantifying cell phenotypes | Q24676898 | ||
| The Hallmarks of Cancer | Q221226 | ||
| Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. | Q41437427 | ||
| Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis | Q41980277 | ||
| CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer | Q43240843 | ||
| Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling | Q46475690 | ||
| beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. | Q52977984 | ||
| Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer. | Q55043806 | ||
| Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer | Q57202934 | ||
| beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma | Q73153525 | ||
| Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression | Q84082530 | ||
| Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications | Q26797616 | ||
| The many faces and functions of β-catenin | Q26865781 | ||
| Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications | Q28076697 | ||
| Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 | ||
| Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells | Q28254617 | ||
| The cell of origin of ovarian epithelial tumours | Q28302089 | ||
| Type-specific cell line models for type-specific ovarian cancer research | Q28536689 | ||
| Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability | Q28609057 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response | Q29617051 | ||
| Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression | Q33719284 | ||
| Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism. | Q33730021 | ||
| ABC transporters in CSCs membranes as a novel target for treating tumor relapse | Q33879326 | ||
| Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Q33957687 | ||
| The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression | Q34179788 | ||
| EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer | Q34202046 | ||
| The role of microRNAs in ovarian cancer | Q34253436 | ||
| Multilayer control of the EMT master regulators | Q34340552 | ||
| The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells | Q34552289 | ||
| Asymmetric mitosis: Unequal segregation of proteins destined for degradation | Q34782639 | ||
| Down-regulation of Filamin A interacting protein 1-like Is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers [corrected] | Q35067854 | ||
| Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment | Q35098085 | ||
| MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma | Q35118920 | ||
| Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer. | Q35169206 | ||
| Promotion of heat shock factor Hsf1 degradation via adaptor protein filamin A-interacting protein 1-like (FILIP-1L). | Q35213186 | ||
| Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer | Q35769582 | ||
| Epithelial-mesenchymal transition in ovarian carcinoma | Q35971814 | ||
| Rethinking ovarian cancer: recommendations for improving outcomes | Q36050883 | ||
| Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer | Q36054860 | ||
| The centrosome in human genetic disease | Q36058438 | ||
| DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination | Q36204976 | ||
| Dynamic association of proteasomal machinery with the centrosome | Q36342153 | ||
| Broad targeting of resistance to apoptosis in cancer. | Q36483749 | ||
| The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients | Q36614683 | ||
| Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta | Q36671104 | ||
| Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients | Q36879739 | ||
| Wnt signaling in ovarian tumorigenesis | Q36953825 | ||
| Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy. | Q37038009 | ||
| Near-infrared fluorescent proteins for multicolor in vivo imaging | Q37079618 | ||
| Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry | Q37113797 | ||
| The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT. | Q37297523 | ||
| Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells | Q37389156 | ||
| Beyond chemotherapy: targeted therapies in ovarian cancer | Q37399899 | ||
| Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas | Q37452255 | ||
| Microenvironmental regulation of ovarian cancer metastasis | Q37599436 | ||
| Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review | Q37612737 | ||
| WNT signaling in ovarian follicle biology and tumorigenesis | Q37624186 | ||
| Epithelial-mesenchymal transition in ovarian cancer. | Q37625486 | ||
| Expression profiles of epithelial-mesenchymal transition-associated proteins in epithelial ovarian carcinoma | Q37706070 | ||
| Advances in epigenetic biomarker research in colorectal cancer | Q37708022 | ||
| Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis | Q37710265 | ||
| Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer | Q37725034 | ||
| Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
| The Wnt/β-catenin pathway in ovarian cancer: a review. | Q38152532 | ||
| The clinical and diagnostic role of microRNAs in ovarian carcinoma | Q38203092 | ||
| Filamin A interacting protein 1-like as a therapeutic target in cancer | Q38247009 | ||
| Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries | Q38332497 | ||
| Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy | Q38350489 | ||
| MicroRNAs in Ovarian Cancer | Q38555569 | ||
| c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling. | Q39314503 | ||
| Snail is critical for tumor growth and metastasis of ovarian carcinoma | Q39792925 | ||
| Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells | Q39834964 | ||
| Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis | Q39915235 | ||
| The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression | Q40112227 | ||
| A novel role of phospho-beta-catenin in microtubule regrowth at centrosome | Q40177769 | ||
| Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced | Q40421321 | ||
| Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer | Q40673230 | ||
| P4510 | describes a project that uses | CellProfiler | Q5058134 |
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 77052-77070 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer | |
| P478 | volume | 7 |
Search more.